Wellington Partners is a leading pan European venture capital firm investing in early and growth stage life science companies across biotechnology, therapeutics, medical devices, diagnostics, and digital health. Since its founding in 1998 it has supported world class entrepreneurs by providing capital and active strategic guidance through a team of experienced MDs and PhDs. The firm collaborates closely with portfolio companies to accelerate preclinical and clinical development, navigate regulatory approval, and support international market entry across Europe, the US, and Asia. With offices in Munich London and Zurich Wellington leverages its global scientific and commercial network to help transform breakthrough ideas into market leading healthcare innovations.